Armodafinil
Who holds supplier records for Armodafinil? 9 organisations hold a current record for Armodafinil: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (7), Iceland (1) and United States (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Armodafinil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/armodafinil
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
7 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Armodafinil. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ACTAVIS GROUP PTC EHFIceland Company GMP cert on recordActive DMF 22983 · latest filing Jul 2009
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 27302 · latest filing Jul 2013
- Cephalon, Inc.United StatesActive DMF 19685 · latest filing Aug 2006
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaActive DMF 40732 · latest filing Mar 2025
- Lupin LimitedIndia Company GMP cert on recordActive DMF 23134 · latest filing Oct 2009
- MATRIX PHARMACORP PRIVATE LTDIndiaActive DMF 21200 · latest filing Dec 2007
- Orchid Pharma LimitedIndia Company GMP cert on recordActive DMF 25031 · latest filing Jun 2011
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 30405 · latest filing Mar 2016
- UNIMARK REMEDIES LTDIndiaActive DMF 24945 · latest filing Jun 2011
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (3)
Organisations whose Type II DMFs for Armodafinil are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 22957 · filed Jul 2009
- SIGMA ALDRICH IRELAND LTDInactive DMF 18107 · filed Feb 2005
- NOVASEP PROCESS SASInactive DMF 18109 · filed Feb 2005
Overview
Armodafinil is a wakefulness-promoting agent used to treat excessive sleepiness associated with narcolepsy, shift work disorder, and obstructive sleep apnea. It is the R-enantiomer of modafinil and is believed to work by altering the amount of certain natural substances in the brain that control sleep and wakefulness.
Chemical identity
- IUPAC name
- 2-[(R)-benzhydrylsulfinyl]acetamide
- Canonical SMILES
- C1=CC=C(C=C1)C(C2=CC=CC=C2)[S@](=O)CC(=O)N
- InChIKey
- YFGHCGITMMYXAQ-AABEYWSASA-N
- Synonyms
- Nuvigil API
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Armodafinil?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Armodafinil: ACTAVIS GROUP PTC EHF (Iceland), APITORIA PHARMA PRIVATE LTD (India), Cephalon, Inc. (United States), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Lupin Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), Orchid Pharma Limited (India) and Piramal Pharma Limited (India), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Armodafinil Drug Master Files are active?
ACTAVIS GROUP PTC EHF (DMF 22983), APITORIA PHARMA PRIVATE LTD (DMF 27302), Cephalon, Inc. (DMF 19685), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 40732), Lupin Limited (DMF 23134), MATRIX PHARMACORP PRIVATE LTD (DMF 21200), Orchid Pharma Limited (DMF 25031) and Piramal Pharma Limited (DMF 30405) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Armodafinil records mean?
3 organisations have only inactive Type II DMFs for Armodafinil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Armodafinil supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Armodafinil?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.